Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly Total Liabilities (Quarterly) : 108.40B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 108.40B |
| March 31, 2026 | 85.38B |
| December 31, 2025 | 85.94B |
| September 30, 2025 | 91.08B |
| June 30, 2025 | 82.57B |
| March 31, 2025 | 73.54B |
| December 31, 2024 | 64.44B |
| September 30, 2024 | 61.29B |
| June 30, 2024 | 58.24B |
| March 31, 2024 | 51.05B |
| December 31, 2023 | 53.14B |
| September 30, 2023 | 46.61B |
| June 30, 2023 | 43.66B |
| March 31, 2023 | 41.87B |
| December 31, 2022 | 38.71B |
| September 30, 2022 | 37.30B |
| June 30, 2022 | 38.40B |
| March 31, 2022 | 37.46B |
| December 31, 2021 | 39.65B |
| September 30, 2021 | 40.23B |
| June 30, 2021 | 41.15B |
| March 31, 2021 | 39.74B |
| December 31, 2020 | 40.81B |
| September 30, 2020 | 38.95B |
| June 30, 2020 | 37.70B |
| Date | Value |
|---|---|
| March 31, 2020 | 37.91B |
| December 31, 2019 | 36.59B |
| September 30, 2019 | 34.43B |
| June 30, 2019 | 35.81B |
| March 31, 2019 | 35.44B |
| December 31, 2018 | 33.00B |
| September 30, 2018 | 30.47B |
| June 30, 2018 | 30.74B |
| March 31, 2018 | 29.77B |
| December 31, 2017 | 33.31B |
| September 30, 2017 | 28.05B |
| June 30, 2017 | 26.78B |
| March 31, 2017 | 23.52B |
| December 31, 2016 | 24.73B |
| September 30, 2016 | 21.97B |
| June 30, 2016 | 21.82B |
| March 31, 2016 | 19.66B |
| December 31, 2015 | 20.98B |
| September 30, 2015 | 21.06B |
| June 30, 2015 | 21.33B |
| March 31, 2015 | 20.71B |
| December 31, 2014 | 21.79B |
| September 30, 2014 | 16.97B |
| June 30, 2014 | 17.02B |
| March 31, 2014 | 16.41B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Merck & Co., Inc. | 87.82B |
| Pfizer Inc. | 115.64B |
| Bristol Myers Squibb Co. | 65.32B |
| Atai Beckley, Inc. | 88.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.28B |
| Shareholders Equity (Quarterly) | 33.88B |
| Debt to Equity Ratio | 1.621 |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -0.29% |